Health: France Biotech proposes eleven measures to stimulate innovation in France
The France Biotech association, which represents innovative companies in the health sector, recently published a strategic report. With the 2027 presidential election approaching, the organization aims to place medical innovation at the heart of public debate and the country's political priorities.
The document details eleven concrete proposals aimed at transforming the French healthcare system. The main objective is to accelerate the development of new medical technologies and facilitate their market entry. According to France Biotech, these measures are essential to maintain France's competitiveness in the face of international competition.
Among the areas of focus, the association insists on the need to simplify administrative procedures for start-ups and research laboratories. It also calls for better access to funding for biotechnology projects, in order to allow companies to move more quickly from the research phase to the commercialization phase.
Finally, France Biotech highlights the importance of strengthening collaboration between the public and private sectors. By facilitating data exchange and encouraging investment, the organization hopes to create a more favorable environment for scientific discoveries. These proposals will now be submitted to future candidates to inform discussions on the future of healthcare in France.